TECX
Income statement / Annual
Last year (2024), Tectonic Therapeutic, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Tectonic Therapeutic, Inc.'s net income was -$57.98 M.
See Tectonic Therapeutic, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.21 M
|
$850.00 K
|
$380.00 K
|
$45.00 K
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$1.21 M
|
-$850.00 K
|
-$380.00 K
|
-$45.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$41.36 M
|
$36.97 M
|
$25.65 M
|
$10.98 M
|
$86.03 M
|
$54.97 M
|
$35.10 M
|
$15.19 M
|
$2.66 M
|
| General & Administrative Expenses |
$16.65 M
|
$7.68 M
|
$7.18 M
|
$4.63 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.65 M
|
$7.68 M
|
$7.18 M
|
$4.63 M
|
$32.99 M
|
$19.99 M
|
$10.77 M
|
$3.15 M
|
$1.96 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$58.02 M
|
$44.65 M
|
$32.83 M
|
$15.61 M
|
$119.02 M
|
$74.96 M
|
$45.86 M
|
$18.34 M
|
$4.63 M
|
| Cost And Expenses |
$58.02 M
|
$44.65 M
|
$32.83 M
|
$15.61 M
|
$120.23 M
|
$75.81 M
|
$46.24 M
|
$18.39 M
|
$4.63 M
|
| Interest Income |
$4.26 M
|
$581.00 K
|
$149.00 K
|
$0.00
|
$719.00 K
|
$2.93 M
|
$1.73 M
|
$57.00 K
|
$6.00 K
|
| Interest Expense |
$107.00 K
|
$152.00 K
|
$144.00 K
|
$224.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.65 M
|
$1.48 M
|
$1.01 M
|
$364.00 K
|
$1.21 M
|
$850.00 K
|
$380.00 K
|
$45.00 K
|
$0.00
|
| EBITDA |
-$56.23 M |
-$41.19 M |
-$31.03 M |
-$8.12 M |
-$118.51 M |
-$72.12 M |
-$45.98 M |
-$18.60 M |
-$4.66 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$33.00 K
|
$1.83 M
|
$650.00 K
|
$6.68 M
|
$516.00 K
|
$2.84 M
|
-$118.00 K
|
-$262.00 K
|
-$39.00 K
|
| Income Before Tax |
-$57.98 M
|
-$42.82 M
|
-$32.18 M
|
-$8.93 M
|
-$119.71 M
|
-$72.97 M
|
-$46.36 M
|
-$18.65 M
|
-$4.66 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$57.98 M
|
-$42.82 M
|
-$32.18 M
|
-$8.93 M
|
-$119.71 M
|
-$72.97 M
|
-$46.36 M
|
-$18.65 M
|
-$4.66 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.93 |
-11.59 |
-29.05 |
-33.36 |
-39.68 |
-31.92 |
-23.41 |
-9.35 |
-2.34 |
| EPS Diluted |
-3.93 |
-11.53 |
-29.05 |
-33.36 |
-39.68 |
-31.92 |
-23.41 |
-9.35 |
-2.34 |
| Weighted Average Shares Out |
$14.77 M
|
$3.69 M
|
$3.64 M
|
$3.57 M
|
$3.02 M
|
$2.29 M
|
$1.98 M
|
$1.99 M
|
$1.99 M
|
| Weighted Average Shares Out Diluted |
$14.77 M
|
$3.71 M
|
$3.64 M
|
$3.57 M
|
$3.02 M
|
$2.29 M
|
$1.98 M
|
$1.99 M
|
$1.99 M
|
| Link |
|
|
|
|
|
|
|
|
|
